|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
| |
|
|
|
|
|
|
 |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Providers |
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
|
 |
Michael Fried, MD
Director of Hepatology
|
|
 |
|
|
|
|
|
Michael
W. Fried, M.D. is Professor of Medicine and Director
of Hepatology at the University of North Carolina at Chapel
Hill. Dr. Fried has been involved with clinical and laboratory
studies of hepatitis C since 1990 when he served for three years
as a medical staff fellow in the Liver Diseases Section of the
National Institutes of Health. Dr Fried has been the principal
investigator on numerous Phase I, II and III clinical trials
of various antiviral agents for chronic hepatitis B and hepatitis
C. Since his appointment to UNC in 1998, Dr. Fried continues
his commitment to the development of new and more effective
treatments for these and other chronic liver diseases. Dr. Fried
was recently inducted into the American Society of Clinical
Investigation (ASCI), an honor society for clinical investigators.
He is also a recipient of a career development award from the
National Institutes of Health to provide mentorship to young
clinical investigators at UNC. |
|
|
|
|
|
 |
|
|
|
 |
|
|
 |
|
|
 |
|
|
|
|
|
|
Paul
“Skip” Hayashi, M.D. is Assistant
Professor of Medicine and Medical Director of Liver Transplantation
at the University of North Carolina at Chapel Hill. After completion
of a fellowship in gastroenterology at the University of California
Davis, he did two additional hepatology fellowships one in clinical
research at the NIH and another in transplant hepatology at
the University of Colorado. He was a transplant hepatologist
at Saint Louis University prior to coming to UNC in 2006. Dr.
Hayashi is interested in clinical research, particularly liver
transplant outcomes, organ allocation and hepatocellular carcinoma.
He will complete his Masters of Public Health degree later this
year. Dr. Hayashi is dedicated to the delivery of high quality
service in the management of patients with chronic liver diseases
and liver transplantation. |
|
|
|
|
 |
|
|
|
 |
|
 |
 |
|
 |
|
|
|
|
|
Steven
Zacks, M.D., M.P.H.,
FRCPC is Assistant
Professor of Medicine at the University of North Carolina
at Chapel Hill. He received his medical degree in 1991 and
completed a residency in internal medicine in 1994 at the
University of Toronto. After completing a fellowship in gastroenterology
at the State University of New York at Buffalo in 1996, Dr.
Zacks was a senior fellow in hepatology and liver transplantation
at UNC while completing a Masters of Public Health degree
in epidemiology at the UNC School of Public Health. Dr. Zacks
applies his training in clinical research to his interests
in the epidemiology and the evaluation of treatments for chronic
liver disease. |
|
|
|
|
|
 |
| |
|
|
 |
 |
|
|
|
 |
|
|
|
Jama
M. Darling, M.D. is Assistant
Professor of Medicine at the University of North Carolina
at Chapel Hill. She completed a residency in internal medicine
in 1999 at UT Southwestern and a fellowship in gastroenterology
in 2002 at Stanford University. Dr. Darling was awarded an
AASLD advanced hepatology fellowship at the University of
California San Francisco in 2003 where her focus was viral
hepatitis. She was an Assistant Professor of Medicine at UCSF
prior to joining the UNC team in 2005. Dr. Darling maintains
a busy general hepatology practice and her research interests
are viral immunology and HCV/HIV co-infection. |
|
|
|
|
|
|
 |
| |
|
|
|
 |
 |
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
Donna
Evon, Ph.D. is Assistant Professor
of Medicine and a Clinical Psychologist at the University
of North Carolina at Chapel Hill. Dr. Evon completed her predoctoral
internship and postdoctoral fellowship in the UNC School of
Medicine, with specialty training in behavioral medicine and
organ transplantation. She worked with patients with end stage
liver disease, hepatitis C, and alcohol abuse. She joined
the UNC Liver Program in 2004 and works with the hepatitis
C clinical and research programs. Dr. Evon provides psychological
evaluations for patients being considered for antiviral therapy
and helps to manage the neuropsychiatric side effects of interferon-based
therapy. Her research interests include the bio-psycho-social
issues of living with hepatitis C and undergoing antiviral
therapy. |
|
|
|
|
|
|
|
|
 |
| |
|
|
|
 |
 |
|
|
|
 |
|
|
|
Betty
Batey, P.A.-C. is Clinical
Instructor in the Division of Gastroenterology and Hepatology.
Betty has greater than ten years experience caring for patients
with liver disease. Her clinical focus is the care of patients
with advanced liver disease awaiting liver transplantation.
She will complete a Masters of Medical Science from Emory
University later this year. |
|
|
|
|
|
|
 |
| |
|
|
|
 |
 |
|
|
|
 |
|
|
|
Karen
Dougherty MSN, APRN is Clinical
Instructor in the Division of Gastroenterology and Hepatology.
She has been a Nurse Practitioner with the UNC Liver program
for more than 5 years. Karen’s primary clinical responsibility
is the care of those being treated for chronic hepatitis C.
She has tremendous experience in managing the side effects
associated with interferon-based therapies for hepatitis C.
She follows patients at the University as well as in our Greensboro
office. |
|
|
|
|
|
|
 |
| |
|
|
|
 |
 |
|
|
|
 |
|
|
|
Luigi
Troiani, MHS, P.A.-C is Clinical
Instructor in the Division of Gastroenterology and Hepatology.
Luigi recently joined the UNC Liver Program, and his major
clinical responsibility is providing care for patients with
chronic hepatitis C at the University and our Greensboro office.
He also cares for patients with advanced liver disease awaiting
liver transplantation. |
|
|
|
|
|
|
 |
| |
|
|
|
 |
|